AI assistant
DEXCOM INC — Director's Dealing 2016
Aug 10, 2016
30198_dirs_2016-08-10_1c9a9d88-fce3-49e7-b2c2-5159bbdc447f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2016-08-08
Reporting Person: KAHN BARBARA (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-08-08 | Common Stock | S | 6000.0 | $90.5218 | Disposed | 29304 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 12291 | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $90.50 to $90.59. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F2: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee.